↓ Skip to main content

Dove Medical Press

Article Metrics

The societal costs of insomnia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
facebook
1 Facebook page

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
132 Mendeley
Title
The societal costs of insomnia
Published in
Neuropsychiatric Disease and Treatment, December 2010
DOI 10.2147/ndt.s15123
Pubmed ID
Authors

Alan Wade

Abstract

Insomnia can be broadly defined as difficulty initiating or maintaining sleep, or sleep that is not refreshing or of poor quality with negative effect on daytime function. Insomnia can be a primary condition or comorbid to an underlying disorder. Subjective measures of insomnia used in population studies, usually based on complaints of unsatisfactory sleep, put the prevalence at about 10%. Insomnia is more common in the elderly and in women, and is often associated with medical and psychiatric disorders. This review examines the measures used to assess quality of sleep (QOS) and daytime functioning and the impact of insomnia on society using these measures.

Mendeley readers

The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Australia 1 <1%
Unknown 130 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 22%
Student > Bachelor 19 14%
Student > Ph. D. Student 15 11%
Researcher 13 10%
Other 10 8%
Other 25 19%
Unknown 21 16%
Readers by discipline Count As %
Medicine and Dentistry 35 27%
Psychology 32 24%
Agricultural and Biological Sciences 7 5%
Social Sciences 6 5%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 24 18%
Unknown 24 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2017.
All research outputs
#1,132,356
of 11,599,579 outputs
Outputs from Neuropsychiatric Disease and Treatment
#190
of 1,916 outputs
Outputs of similar age
#11,213
of 114,898 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#2
of 29 outputs
Altmetric has tracked 11,599,579 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,916 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 114,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.